State of New Jersey Common Pension Fund D Has $1.97 Million Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

State of New Jersey Common Pension Fund D lowered its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 7.8% during the third quarter, Holdings Channel reports. The fund owned 27,382 shares of the company’s stock after selling 2,319 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Prestige Consumer Healthcare were worth $1,974,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Covestor Ltd lifted its position in shares of Prestige Consumer Healthcare by 21.6% during the first quarter. Covestor Ltd now owns 834 shares of the company’s stock worth $61,000 after purchasing an additional 148 shares in the last quarter. Evergreen Capital Management LLC raised its position in Prestige Consumer Healthcare by 5.4% in the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock worth $216,000 after purchasing an additional 160 shares during the last quarter. Miller Howard Investments Inc. NY lifted its holdings in Prestige Consumer Healthcare by 2.2% during the 2nd quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company’s stock worth $534,000 after buying an additional 165 shares in the last quarter. OLD National Bancorp IN boosted its position in Prestige Consumer Healthcare by 4.4% in the 3rd quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock valued at $287,000 after buying an additional 168 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after buying an additional 208 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Insiders Place Their Bets

In related news, insider William P’pool sold 8,987 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total value of $735,585.95. Following the sale, the insider now directly owns 20,058 shares in the company, valued at $1,641,747.30. This trade represents a 30.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Mary Beth Fritz sold 9,885 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total transaction of $810,273.45. Following the transaction, the senior vice president now directly owns 18,835 shares in the company, valued at $1,543,904.95. The trade was a 34.42 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,935 shares of company stock worth $2,289,025. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on PBH shares. DA Davidson restated a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. Jefferies Financial Group reissued a “hold” rating and set a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $83.67.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $82.36 on Monday. The firm’s 50 day moving average price is $73.29 and its two-hundred day moving average price is $70.24. The stock has a market cap of $4.07 billion, a PE ratio of 20.04, a PEG ratio of 2.32 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 52-week low of $56.61 and a 52-week high of $83.83. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.09. The business had revenue of $283.79 million for the quarter, compared to analyst estimates of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The firm’s revenue was down .9% on a year-over-year basis. During the same period last year, the company earned $1.07 EPS. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.